There's almost no risk that the current brilacidin study will return results that will allow for a statistically significant differentiation of brilacidin plus SOC vs SOC alone.
I believe that was the intent behind the design of the study.
You and I are dependent on this pulling through for our retirements. That doesn't mean we should put others at risk stating this is not high risk.
Should B-COVID fail I wouldn't want to see someone else get crushed holding too much in yet another gamble like we have been over the years. Make sure you have enough to partake in the winnings but please don't over allocate like I have.
News 
Market Data 
Discover 
AI
